$QDEL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUIDEL CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUIDEL CORP /DE/. Get notifications about new insider transactions in QUIDEL CORP /DE/ for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | QDEL | QUIDEL CORP /DE/ | Hodges Michelle A. | SVP, General Counse ... | Option Exercise | A | 0.00 | 1,680 | 0 | 1,680 | |
May 20 2021 | QDEL | QUIDEL CORP /DE/ | Wilkins Joseph D Jr. | Director | Option Exercise | A | 0.00 | 1,624 | 0 | 1,624 | |
May 20 2021 | QDEL | QUIDEL CORP /DE/ | BUECHLER KENNETH F | Director | Option Exercise | A | 0.00 | 236 | 0 | 236 | |
May 20 2021 | QDEL | QUIDEL CORP /DE/ | BUECHLER KENNETH F | Director | Option Exercise | A | 0.00 | 789 | 0 | 789 | |
May 20 2021 | QDEL | QUIDEL CORP /DE/ | BUECHLER KENNETH F | Director | Option Exercise | A | 0.00 | 1,624 | 0 | 1,624 | |
May 18 2021 | QDEL | QUIDEL CORP /DE/ | WIDDER KENNETH J | Director | Option Exercise | M | 0.00 | 576 | 0 | 0 | |
May 18 2021 | QDEL | QUIDEL CORP /DE/ | WIDDER KENNETH J | Director | Buy | M | 0.00 | 576 | 0 | 16,032 | 15.5 K to 16 K (+3.73 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Wilkins Joseph D Jr. | Director | Option Exercise | M | 0.00 | 289 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Wilkins Joseph D Jr. | Director | Buy | M | 0.00 | 289 | 0 | 289 | 0 to 289 |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | WIDDER KENNETH J | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | WIDDER KENNETH J | Director | Buy | M | 0.00 | 1,040 | 0 | 15,456 | 14.4 K to 15.5 K (+7.21 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Strobeck Matthew | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Strobeck Matthew | Director | Buy | M | 0.00 | 1,040 | 0 | 4,909 | 3.9 K to 4.9 K (+26.88 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Option Exercise | M | 0.00 | 122 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Option Exercise | M | 0.00 | 612 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Option Exercise | M | 0.00 | 19 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Option Exercise | M | 0.00 | 191 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Buy | M | 0.00 | 122 | 0 | 12,199 | 12.1 K to 12.2 K (+1.01 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Buy | M | 0.00 | 612 | 0 | 12,077 | 11.5 K to 12.1 K (+5.34 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Sell | S | 113.26 | 1,000 | 113,258 | 11,465 | 12.5 K to 11.5 K (-8.02 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Buy | M | 0.00 | 19 | 0 | 12,465 | 12.4 K to 12.5 K (+0.15 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Buy | M | 0.00 | 191 | 0 | 12,446 | 12.3 K to 12.4 K (+1.56 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | SLACIK CHARLES P | Director | Buy | M | 0.00 | 1,040 | 0 | 12,255 | 11.2 K to 12.3 K (+9.27 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Option Exercise | M | 0.00 | 624 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | RHOADS ANN D | Director | Buy | M | 0.00 | 624 | 0 | 624 | 0 to 624 |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | POLAN MARY LAKE PH D | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | POLAN MARY LAKE PH D | Director | Buy | M | 0.00 | 1,040 | 0 | 25,369 | 24.3 K to 25.4 K (+4.27 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | ORDONEZ KATHY | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | ORDONEZ KATHY | Director | Buy | M | 0.00 | 1,040 | 0 | 2,896 | 1.9 K to 2.9 K (+56.03 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Michael Edward L. | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | Michael Edward L. | Director | Buy | M | 0.00 | 1,040 | 0 | 7,474 | 6.4 K to 7.5 K (+16.16 %) |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | BUECHLER KENNETH F | Director | Option Exercise | M | 0.00 | 1,040 | 0 | 0 | |
May 14 2021 | QDEL | QUIDEL CORP /DE/ | BUECHLER KENNETH F | Director | Buy | M | 0.00 | 1,040 | 0 | 60,864 | 59.8 K to 60.9 K (+1.74 %) |
May 04 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 23.41 | 803 | 18,798 | 460 | |
May 04 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Sell | S | 105.74 | 803 | 84,909 | 5,324 | 6.1 K to 5.3 K (-13.11 %) |
May 04 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Buy | M | 23.41 | 803 | 18,798 | 6,127 | 5.3 K to 6.1 K (+15.08 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 210.10 | 2,396 | 503,400 | 15,169 | 17.6 K to 15.2 K (-13.64 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 4,831 | 0 | 17,565 | 12.7 K to 17.6 K (+37.94 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 210.10 | 2,379 | 499,828 | 12,734 | 15.1 K to 12.7 K (-15.74 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 4,798 | 0 | 15,113 | 10.3 K to 15.1 K (+46.51 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 0.00 | 434 | 0 | 1,302 | |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 126.39 | 216 | 27,300 | 5,324 | 5.5 K to 5.3 K (-3.90 %) |
Apr 01 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Buy | M | 0.00 | 434 | 0 | 5,540 | 5.1 K to 5.5 K (+8.50 %) |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 15.40 | 3,910 | 60,214 | 0 | |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 23.41 | 691 | 16,176 | 1,263 | |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Sell | S | 136.05 | 2,799 | 380,801 | 5,106 | 7.9 K to 5.1 K (-35.41 %) |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Sell | S | 136.07 | 4,601 | 626,037 | 7,905 | 12.5 K to 7.9 K (-36.79 %) |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Buy | M | 15.40 | 3,910 | 60,214 | 12,506 | 8.6 K to 12.5 K (+45.49 %) |
Mar 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Buy | M | 23.41 | 691 | 16,176 | 8,596 | 7.9 K to 8.6 K (+8.74 %) |
Mar 02 2021 | QDEL | QUIDEL CORP /DE/ | Wilkins Joseph D Jr. | Director | Option Exercise | A | 0.00 | 289 | 0 | 289 | |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 59.12 | 3,926 | 232,105 | 3,924 | |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 47.85 | 2,970 | 142,115 | 0 | |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 46.41 | 2,303 | 106,882 | 2,303 | |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 21.08 | 3,585 | 75,572 | 0 | |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 173.71 | 5,283 | 917,734 | 8,119 | 13.4 K to 8.1 K (-39.42 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 164.59 | 173 | 28,474 | 13,402 | 13.6 K to 13.4 K (-1.27 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 166.36 | 4,662 | 775,584 | 13,575 | 18.2 K to 13.6 K (-25.56 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Sell | S | 164.11 | 12,784 | 2,097,955 | 18,237 | 31 K to 18.2 K (-41.21 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 59.12 | 3,926 | 232,105 | 31,021 | 27.1 K to 31 K (+14.49 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 47.85 | 2,970 | 142,115 | 27,095 | 24.1 K to 27.1 K (+12.31 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 46.41 | 2,303 | 106,882 | 24,125 | 21.8 K to 24.1 K (+10.55 %) |
Feb 24 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Buy | M | 21.08 | 3,585 | 75,572 | 21,822 | 18.2 K to 21.8 K (+19.66 %) |
Feb 22 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Buy | P | 165.30 | 5,000 | 826,500 | 495,807 | 490.8 K to 495.8 K (+1.02 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 210.10 | 1,797 | 377,550 | 26,126 | 27.9 K to 26.1 K (-6.44 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 3,623 | 0 | 27,923 | 24.3 K to 27.9 K (+14.91 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 210.10 | 2,284 | 479,868 | 24,300 | 26.6 K to 24.3 K (-8.59 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 4,606 | 0 | 26,584 | 22 K to 26.6 K (+20.96 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 210.10 | 585 | 122,909 | 12,063 | 12.6 K to 12.1 K (-4.63 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 1,510 | 0 | 12,648 | 11.1 K to 12.6 K (+13.56 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 210.10 | 421 | 88,452 | 11,138 | 11.6 K to 11.1 K (-3.64 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 1,727 | 0 | 11,559 | 9.8 K to 11.6 K (+17.57 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 1,055 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 3,519 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 210.10 | 2,016 | 423,562 | 18,237 | 20.3 K to 18.2 K (-9.95 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 3,925 | 0 | 20,253 | 16.3 K to 20.3 K (+24.04 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 210.10 | 2,366 | 497,097 | 16,328 | 18.7 K to 16.3 K (-12.66 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 4,606 | 0 | 18,694 | 14.1 K to 18.7 K (+32.69 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 217.79 | 542 | 118,042 | 14,088 | 14.6 K to 14.1 K (-3.70 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 1,055 | 0 | 14,630 | 13.6 K to 14.6 K (+7.77 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 217.79 | 1,725 | 375,688 | 13,575 | 15.3 K to 13.6 K (-11.27 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 3,519 | 0 | 15,300 | 11.8 K to 15.3 K (+29.87 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 210.10 | 824 | 173,122 | 7,812 | 8.6 K to 7.8 K (-9.54 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,661 | 0 | 8,636 | 7 K to 8.6 K (+23.81 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 210.10 | 857 | 180,056 | 6,975 | 7.8 K to 7 K (-10.94 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,727 | 0 | 7,832 | 6.1 K to 7.8 K (+28.29 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 210.10 | 824 | 173,122 | 7,310 | 8.1 K to 7.3 K (-10.13 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 1,661 | 0 | 8,134 | 6.5 K to 8.1 K (+25.66 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 210.10 | 633 | 132,993 | 6,473 | 7.1 K to 6.5 K (-8.91 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 1,727 | 0 | 7,106 | 5.4 K to 7.1 K (+32.11 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,094 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 3,646 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 210.10 | 1,797 | 377,550 | 25,167 | 27 K to 25.2 K (-6.66 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 3,623 | 0 | 26,964 | 23.3 K to 27 K (+15.52 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 210.10 | 2,284 | 479,868 | 23,341 | 25.6 K to 23.3 K (-8.91 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 4,606 | 0 | 25,625 | 21 K to 25.6 K (+21.91 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 217.79 | 543 | 118,260 | 21,019 | 21.6 K to 21 K (-2.52 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 1,094 | 0 | 21,562 | 20.5 K to 21.6 K (+5.34 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 217.79 | 1,723 | 375,252 | 20,468 | 22.2 K to 20.5 K (-7.76 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 3,646 | 0 | 22,191 | 18.5 K to 22.2 K (+19.66 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 2,808 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 9,363 | 0 | 0 | |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 210.10 | 9,282 | 1,950,148 | 490,807 | 500.1 K to 490.8 K (-1.86 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 18,720 | 0 | 500,089 | 481.4 K to 500.1 K (+3.89 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 210.10 | 6,851 | 1,439,395 | 481,369 | 488.2 K to 481.4 K (-1.40 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 13,818 | 0 | 488,220 | 474.4 K to 488.2 K (+2.91 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 217.79 | 1,393 | 303,381 | 474,402 | 475.8 K to 474.4 K (-0.29 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 2,808 | 0 | 475,795 | 473 K to 475.8 K (+0.59 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 217.79 | 4,423 | 963,285 | 472,987 | 477.4 K to 473 K (-0.93 %) |
Feb 19 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 9,363 | 0 | 477,410 | 468 K to 477.4 K (+2.00 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 227.97 | 3,470 | 791,056 | 21,978 | 25.4 K to 22 K (-13.64 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 7,172 | 0 | 25,448 | 18.3 K to 25.4 K (+39.24 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,594 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 227.97 | 3,766 | 858,535 | 10,315 | 14.1 K to 10.3 K (-26.75 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 7,594 | 0 | 14,081 | 6.5 K to 14.1 K (+117.06 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | M | 0.00 | 675 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 227.97 | 165 | 37,615 | 9,832 | 10 K to 9.8 K (-1.65 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 675 | 0 | 9,997 | 9.3 K to 10 K (+7.24 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 227.97 | 3,683 | 839,614 | 11,781 | 15.5 K to 11.8 K (-23.82 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 7,172 | 0 | 15,464 | 8.3 K to 15.5 K (+86.49 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | M | 0.00 | 3,797 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 227.97 | 1,883 | 429,268 | 6,105 | 8 K to 6.1 K (-23.57 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 3,797 | 0 | 7,988 | 4.2 K to 8 K (+90.60 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 0.00 | 675 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Payment of Exercise | F | 227.97 | 234 | 53,345 | 5,379 | 5.6 K to 5.4 K (-4.17 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Grant | A | 0.00 | 675 | 0 | 5,613 | 4.9 K to 5.6 K (+13.67 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,172 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Payment of Exercise | F | 227.97 | 3,556 | 810,661 | 18,545 | 22.1 K to 18.5 K (-16.09 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | Bujarski Robert Joseph | Chief Operating Off ... | Grant | A | 0.00 | 7,172 | 0 | 22,101 | 14.9 K to 22.1 K (+48.04 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Option Exercise | M | 0.00 | 20,250 | 0 | 0 | |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Payment of Exercise | F | 227.97 | 10,040 | 2,288,819 | 468,047 | 478.1 K to 468 K (-2.10 %) |
Feb 17 2021 | QDEL | QUIDEL CORP /DE/ | BRYANT DOUGLAS C | President & CEO | Grant | A | 0.00 | 20,250 | 0 | 478,087 | 457.8 K to 478.1 K (+4.42 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,616 | 0 | 11,232 | |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Payment of Exercise | F | 236.85 | 2,498 | 591,651 | 6,487 | 9 K to 6.5 K (-27.80 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | STEWARD RANDALL J | Chief Financial Off ... | Grant | A | 0.00 | 5,616 | 0 | 8,985 | 3.4 K to 9 K (+166.70 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Option Exercise | M | 0.00 | 1,661 | 0 | 4,980 | |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Payment of Exercise | F | 236.85 | 575 | 136,189 | 18,276 | 18.9 K to 18.3 K (-3.05 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Russell Edward Keith | SVP, Business Devel ... | Grant | A | 0.00 | 1,661 | 0 | 18,851 | 17.2 K to 18.9 K (+9.66 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Option Exercise | M | 0.00 | 593 | 0 | 1,779 | |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Payment of Exercise | F | 236.85 | 145 | 34,343 | 9,302 | 9.4 K to 9.3 K (-1.53 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ranalli Tamara A. | SVP, Molecular Bus. ... | Grant | A | 0.00 | 593 | 0 | 9,447 | 8.9 K to 9.4 K (+6.70 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Option Exercise | M | 0.00 | 4,268 | 0 | 8,536 | |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Payment of Exercise | F | 228.68 | 2,192 | 501,267 | 8,225 | 10.4 K to 8.2 K (-21.04 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Kroll Werner | SVP, R&D | Grant | A | 0.00 | 4,268 | 0 | 10,417 | 6.1 K to 10.4 K (+69.41 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Option Exercise | M | 0.00 | 1,661 | 0 | 4,980 | |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Payment of Exercise | F | 236.85 | 824 | 195,164 | 4,151 | 5 K to 4.2 K (-16.56 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | GIBSON KAREN | SVP, Digital Health | Grant | A | 0.00 | 1,661 | 0 | 4,975 | 3.3 K to 5 K (+50.12 %) |
Feb 05 2021 | QDEL | QUIDEL CORP /DE/ | Ferenczy William J. | SVP, Cardio/Metabol ... | Option Exercise | M | 0.00 | 653 | 0 | 1,956 |